Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award - PA: Digestive Health (SHOPP)

University of Calgary

$52,500.00

Regulation of macrophage activity by interleukin-6

FY 2011-12

Summary
Inflammatory bowel disease (IBD) describes two chronically occurring conditions of the gut: Crohn's disease and ulcerative colitis - permanent conditions that dramatically reduce the quality of life of those afflicted. Canada currently has one of the highest rates of IBD in the world. The exact cause of IBD has not been determined, but it is thought to be associated with an uncontrolled immune response to the normal bacterial flora of the intestine. In this regard, macrophages are an interesting focus of study, as they are a cell that can respond to bacteria and exert either pro- or anti-inflammatory effects. In the McKay laboratory, a particular subtype of macrophages known as alternatively activated macrophages (AAMs) have been shown to reduce the severity of chemically-induced colitis in murine models. The mechanism(s) by which these cells exert there effect has not yet been determined. Therefore, the focus of this project is to study how the in vivo environment influences the induction and function of AAMs, focusing in particular on the cytokine interleukin(IL)-6. IL-6 is an important molecule, constitutively produced by many tissues of the body and up-regulated in a number of inflammatory diseases, including IBD. Preliminary data has indicated that IL-6 is able to enhance the phenotype and anti-inflammatory properties of AAMs by a yet undetermined mechanism. Determining the role of IL-6 (if any) in the in vivo differentiation of AAMs will provide useful information which could potentially be used to translate data derived from murine studies into an individually targeted therapy for patients with IBD.
Program
Doctoral Research Award - PA: Digestive Health (SHOPP)
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
245673
Name
Fernando Maria R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Digestive Health Foundation
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Regulation of macrophage activity by interleukin-6
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$52,500
Cihrequipment2
$0
Programname2
Doctoral Research Award - PA: Digestive Health (SHOPP)
Keyworddelim
Alternatively Activated Macrophages; Colitis; Gastrointestinal System; Immunology; Inflammatory Bowel Disease; Interleukin-6
Abstract
Inflammatory bowel disease (IBD) describes two chronically occurring conditions of the gut: Crohn's disease and ulcerative colitis - permanent conditions that dramatically reduce the quality of life of those afflicted. Canada currently has one of the highest rates of IBD in the world. The exact cause of IBD has not been determined, but it is thought to be associated with an uncontrolled immune response to the normal bacterial flora of the intestine. In this regard, macrophages are an interesting focus of study, as they are a cell that can respond to bacteria and exert either pro- or anti-inflammatory effects. In the McKay laboratory, a particular subtype of macrophages known as alternatively activated macrophages (AAMs) have been shown to reduce the severity of chemically-induced colitis in murine models. The mechanism(s) by which these cells exert there effect has not yet been determined. Therefore, the focus of this project is to study how the in vivo environment influences the induction and function of AAMs, focusing in particular on the cytokine interleukin(IL)-6. IL-6 is an important molecule, constitutively produced by many tissues of the body and up-regulated in a number of inflammatory diseases, including IBD. Preliminary data has indicated that IL-6 is able to enhance the phenotype and anti-inflammatory properties of AAMs by a yet undetermined mechanism. Determining the role of IL-6 (if any) in the in vivo differentiation of AAMs will provide useful information which could potentially be used to translate data derived from murine studies into an individually targeted therapy for patients with IBD.
Competitiondate
201110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Fernando, Maria R
Approvedterm
3 ans 0 mois
Cihrcontribution2
SPIR~ $52,500~ $0~